SummerHaven Investment Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,915
Closed -$1.19M 274
2024
Q2
$1.19M Buy
8,915
+115
+1% +$13.8K 0.78% 18
2024
Q1
$925K Buy
8,800
+115
+1% +$10.3K 0.58% 64
2023
Q4
$656K Buy
8,685
+145
+2% +$9.19K 0.42% 150
2023
Q3
$563K Sell
8,540
-4,605
-35% -$344K 0.41% 167
2023
Q2
$1.07M Sell
13,145
-1,635
-11% -$116K 0.68% 34
2023
Q1
$878K Buy
14,780
+300
+2% +$16.7K 0.51% 89
2022
Q4
$706K Buy
14,480
+250
+2% +$11.6K 0.42% 146
2022
Q3
$734K Buy
14,230
+1,237
+10% +$73.4K 0.51% 84
2022
Q2
$683K Hold
12,993
0.46% 118
2022
Q1
$1.12M Buy
12,993
+576
+5% +$47.3K 0.63% 39
2021
Q4
$1.01M Hold
12,417
0.55% 59
2021
Q3
$825K Sell
12,417
-11,604
-48% -$823K 0.48% 119
2021
Q2
$1.61M Buy
24,021
+594
+3% +$36.8K 0.92% 8
2021
Q1
$1.22M Hold
23,427
0.74% 15
2020
Q4
$935K Buy
+23,427
New +$756K 0.72% 13

Other funds holding THC

SummerHaven Investment Management's THC Position: Q3 2024 in Review

SummerHaven Investment Management sold out of Tenet Healthcare (THC) in Q3 2024, closing a stake of 8,915 shares — an estimated $1.19M sold.

SummerHaven Investment Management first reported a position in THC in Q4 2020 and held it in 15 quarters. The position peaked at $1.61M in Q2 2021. 602 funds tracked by Wall St. Rank hold THC as of Q3 2024.

  • SummerHaven Investment Management reported no remaining Tenet Healthcare position as of Q3 2024 after selling out during the quarter.
  • SummerHaven Investment Management sold 8,915 Tenet Healthcare shares in Q3 2024, an estimated $1.19M.
  • SummerHaven Investment Management first reported a position in Tenet Healthcare in Q4 2020 and held it in 15 quarters.
  • SummerHaven Investment Management's Tenet Healthcare position peaked at $1.61M in Q2 2021.
  • 602 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on SummerHaven Investment Management's 13F filing for Q3 2024, filed 16 Oct 2024.